Ke Si Wang
Impact in
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents
-
- Medicinal plant effects and applications
- Traditional Chinese Medicine Analysis
Papers in
-
- Natural product bioactivities and synthesis 4
- Bioactive natural compounds 2
- PI3K/AKT/mTOR signaling in cancer 2
- RNA modifications and cancer 1
-
- NF-κB Signaling Pathways 5
- Cancer, Hypoxia, and Metabolism 5
- Cancer-related molecular mechanisms research 2
- Co-authors
- Chunliu Mi (15 shared papers)Juan Ma (14 shared papers)Lian Xun Piao (9 shared papers)Xuezheng Li (9 shared papers)Guang Xu (9 shared papers)Xuejun Jin (8 shared papers)Jung Joon Lee (8 shared papers)Xuejun Jin (6 shared papers)
- Journals
- Oncology Reports (3 papers)Chemico-Biological Interactions (2 papers)International Immunopharmacology (2 papers)Immunopharmacology and Immunotoxicology (2 papers)Oncotarget (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Ke Si Wang
15 papers receiving 573 citations
Peers
Comparison fields: 5 of 84
- Toxicology 31
- Complementary and alternative medicine 68
- Cancer Research 97
- Pharmacology 82
- Molecular Biology 287
Countries citing papers authored by Ke Si Wang
This map shows the geographic impact of Ke Si Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Si Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Si Wang more than expected).
Fields of papers citing papers by Ke Si Wang
This network shows the impact of papers produced by Ke Si Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Si Wang. The network helps show where Ke Si Wang may publish in the future.
Co-authors
The 22 scholars most cited alongside Ke Si Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 103 | |
| 2 | 2016 | 90 | |
| 3 | 2017 | 53 | |
| 4 | 2016 | 48 | |
| 5 | 2017 | 47 | |
| 6 | 2016 | 44 | |
| 7 | 2016 | 44 | |
| 8 | 2015 | 38 | |
| 9 | 2017 | 30 | |
| 10 | 2016 | 25 | |
| 11 | 2017 | 19 | |
| 12 | 2015 | 14 | |
| 13 | 2015 | 12 | |
| 14 | 2016 | 6 | |
| 15 | 2021 | 1 |
About Ke Si Wang
Ke Si Wang is a scholar working on Molecular Biology, Cancer Research, Pharmacology, Complementary and alternative medicine and Immunology, having authored 15 papers that have together received 574 indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Natural product bioactivities and synthesis (4 papers), Bioactive natural compounds (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Cancer-related molecular mechanisms research (2 papers), RNA modifications and cancer (1 paper) and Flavonoids in Medical Research (1 paper). The work is most often cited by research in Toxicology (31 citations), Complementary and alternative medicine (68 citations), Cancer Research (97 citations), Pharmacology (82 citations) and Molecular Biology (287 citations). Ke Si Wang has collaborated with scholars based in China and United States. Frequent co-authors include Chunliu Mi, Juan Ma, Lian Xun Piao, Xuezheng Li, Guang Xu, Xuejun Jin, Jung Joon Lee, Xuejun Jin, Zhe Wang and Ming Yue Li. Their work appears in journals such as Oncology Reports, Chemico-Biological Interactions, International Immunopharmacology, Immunopharmacology and Immunotoxicology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.